NEW YORK, July 27 (GenomeWeb News) - Third Wave Technologies today reported an increase in its second-quarter revenues, accompanied by narrowed losses and a rise in R&D spending. Additionally, the company announced that its board of directors has approved a stock repurchase plan for up to 5 percent of the company's 40.4 million outstanding shares.
Already have a GenomeWeb or 360Dx account?Login Now.
The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.
A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.
Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.
In Science this week: analysis of DNA from ancient North Africans, and more.